- Home
- ACIU vs CPS Comparison
ACIU vs CPS Comparison
Compare ACIU & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- CPS
- Stock Information
- Founded
- ACIU 2003
- CPS 1960
- Country
- ACIU Switzerland
- CPS United States
- Employees
- ACIU N/A
- CPS N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- CPS Auto Parts:O.E.M.
- Sector
- ACIU Health Care
- CPS Consumer Discretionary
- Exchange
- ACIU Nasdaq
- CPS Nasdaq
- Market Cap
- ACIU 332.4M
- CPS 280.3M
- IPO Year
- ACIU 2016
- CPS N/A
- Fundamental
- Price
- ACIU $3.15
- CPS $14.83
- Analyst Decision
- ACIU Strong Buy
- CPS
- Analyst Count
- ACIU 2
- CPS 0
- Target Price
- ACIU $12.00
- CPS N/A
- AVG Volume (30 Days)
- ACIU 151.5K
- CPS 127.8K
- Earning Date
- ACIU 11-05-2024
- CPS 10-31-2024
- Dividend Yield
- ACIU N/A
- CPS N/A
- EPS Growth
- ACIU N/A
- CPS N/A
- EPS
- ACIU N/A
- CPS N/A
- Revenue
- ACIU $48,505,404.00
- CPS $2,743,783,000.00
- Revenue This Year
- ACIU $85.33
- CPS N/A
- Revenue Next Year
- ACIU $80.69
- CPS $9.07
- P/E Ratio
- ACIU N/A
- CPS N/A
- Revenue Growth
- ACIU 4097200.00
- CPS N/A
- 52 Week Low
- ACIU $2.25
- CPS $11.24
- 52 Week High
- ACIU $5.14
- CPS $20.82
- Technical
- Relative Strength Index (RSI)
- ACIU 45.68
- CPS 51.80
- Support Level
- ACIU $3.10
- CPS $14.28
- Resistance Level
- ACIU $3.25
- CPS $15.51
- Average True Range (ATR)
- ACIU 0.14
- CPS 0.66
- MACD
- ACIU -0.02
- CPS -0.06
- Stochastic Oscillator
- ACIU 13.16
- CPS 61.43
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is a supplier of rubber and resin products for the automotive industry. The company produces rubber and plastic sealings, fuel and brake lines, fluid transfer hoses, and anti-vibration systems used by original equipment manufacturers and replacement markets for passenger vehicles and light trucks. The largest customers include Ford, GM, FCA, Peugeot Citroen, and Volkswagen. Cooper Standard generates the majority of its revenue with its sealing systems products such as Fortrex, dynamic and static seals, stainless steel trims, flush glass systems, and variable extrusions.